SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J Sistonen, P Madadi, C J Ross, M Yazdanpanah, J W Lee, M L A Landsmeer, M Nauta, B C Carleton, G Koren, M R Hayden, Prediction of Codeine Toxicity in Infants and Their Mothers Using a Novel Combination of Maternal Genetic Markers, Clinical Pharmacology & Therapeutics, 2012, 91, 4, 692

    CrossRef

  2. 2
    César Fernández-de-las-Peñas, Carolina Fernández-Lao, Irene Cantarero-Villanueva, Silvia Ambite-Quesada, Inés Rivas-Martínez, Rosario Moral-Avila, Manuel Arroyo-Morales, Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors, Breast Cancer Research and Treatment, 2011, 133, 2, 405

    CrossRef

  3. 3
    Yuri Kolesnikov, Boris Gabovits, Ariel Levin, Edward Voiko, Andres Veske, Combined Catechol-O-Methyltransferase and μ-Opioid Receptor Gene Polymorphisms Affect Morphine Postoperative Analgesia and Central Side Effects, Anesthesia & Analgesia, 2011, 112, 2, 448

    CrossRef

  4. 4
    J. Droney, J. Riley, J.R. Ross, Evolving Knowledge of Opioid Genetics in Cancer Pain, Clinical Oncology, 2011, 23, 6, 418

    CrossRef

  5. 5
    P. Klepstad, T. Fladvad, F. Skorpen, K. Bjordal, A. Caraceni, O. Dale, A. Davies, M. Kloke, S. Lundström, M. Maltoni, L. Radbruch, R. Sabatowski, V. Sigurdardottir, F. Strasser, P.M. Fayers, S. Kaasa, Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2294 cancer pain patients, PAIN, 2011, 152, 5, 1139

    CrossRef

  6. 6
    Arjun Muralidharan, Maree T. Smith, Pain, analgesia and genetics, Journal of Pharmacy and Pharmacology, 2011, 63, 11
  7. 7
    Barbara M. Raudonis, Denise M. Cauble, Palliative Care in the Genomic Era, Journal of Hospice & Palliative Nursing, 2011, 13, 5, 298

    CrossRef

  8. 8
    Anne Emilia Tammimäki, Pekka T. Männistö, Are genetic variants of COMT associated with addiction?, Pharmacogenetics and Genomics, 2010, 1

    CrossRef

  9. 9
    Feng Dai, Inna Belfer, Carolyn E. Schwartz, Robert Banco, Julia F. Martha, Hocine Tighioughart, Scott G. Tromanhauser, Louis G. Jenis, David H. Kim, Association of catechol-O-methyltransferase genetic variants with outcome in patients undergoing surgical treatment for lumbar degenerative disc disease, The Spine Journal, 2010, 10, 11, 949

    CrossRef

  10. 10
    Qiuling Shi, Charles S. Cleeland, PÃ¥l Klepstad, Christine Miaskowski, Nancy L. Pedersen, Biological pathways and genetic variables involved in pain, Quality of Life Research, 2010, 19, 10, 1407

    CrossRef

  11. 11
    Jeffrey L. Galinkin, Laurie Demmer, Myron Yaster, Genetics for the Pediatric Anesthesiologist, Anesthesia & Analgesia, 2010, 111, 5, 1264

    CrossRef

  12. 12
    Ulrike M Stamer, Lan Zhang, Frank Stüber, Personalized therapy in pain management: where do we stand?, Pharmacogenomics, 2010, 11, 6, 843

    CrossRef

  13. 13
    Ana M. Peiró, César Margarit, Paula Giménez, José F. Horga, Pharmacogenetic Testing Is of Limited Utility for Predicting Analgesic Response to Morphine, Journal of Pain and Symptom Management, 2010, 39, 1, e8

    CrossRef

  14. 14
    Maren Kleine-Brueggeney, Frank Musshoff, Frank Stuber, Ulrike M. Stamer, Pharmacogenetics in palliative care, Forensic Science International, 2010, 203, 1-3, 63

    CrossRef

  15. 15
    David H. Kim, Carolyn E. Schwartz, The genetics of pain: implications for evaluation and treatment of spinal disease, The Spine Journal, 2010, 10, 9, 827

    CrossRef

  16. 16
    Oleg Kambur, Pekka T. Männistö, Basic Aspects of Catechol-O-Methyltransferase and the Clinical Applications of its Inhibitors, 2010,

    CrossRef

  17. 17
    A.H. Ghodse, S. Galea, Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions, 2010,

    CrossRef

  18. 18
    Branka Kosarac, Amanda A Fox, Charles D Collard, Effect of genetic factors on opioid action, Current Opinion in Anaesthesiology, 2009, 22, 4, 476

    CrossRef

  19. 19
    Hyungsuk Kim, David Clark, Raymond A. Dionne, Genetic Contributions to Clinical Pain and Analgesia: Avoiding Pitfalls in Genetic Research, The Journal of Pain, 2009, 10, 7, 663

    CrossRef

  20. 20
    Alessandro Panconesi, Maria Letizia Bartolozzi, Leonello Guidi, Migraine pain: reflections against vasodilatation, The Journal of Headache and Pain, 2009, 10, 5, 317

    CrossRef

  21. 21
    Neal E. Slatkin, Opioid switching and rotation in primary care: implementation and clinical utility, Current Medical Research and Opinion, 2009, 25, 9, 2133

    CrossRef

  22. 22
    Célia Lloret Linares, Xavier Declèves, Jean Michel Oppert, Arnaud Basdevant, Karine Clement, Christophe Bardin, Jean Michel Scherrmann, Jean Pierre Lepine, Jean François Bergmann, Stéphane Mouly, Pharmacology of Morphine in Obese Patients, Clinical Pharmacokinetics, 2009, 48, 10, 635

    CrossRef

  23. 23
    Tara Sanft, Joshua Hauser, Drew Rosielle, David Weissman, Ahmed Elsayem, Donna S. Zhukovsky, Nessa Coyle, Physical Pain and Emotional Suffering: The Case for Palliative Sedation, The Journal of Pain, 2009, 10, 3, 238

    CrossRef

  24. 24
    Christine Miaskowski, Understanding the Genetic Determinants of Pain and Pain Management, Seminars in Oncology Nursing, 2009, 25, 2, S1

    CrossRef

  25. 25
    Sonja Andersen, Frank Skorpen, Variation in theCOMTgene: implications for pain perception and pain treatment, Pharmacogenomics, 2009, 10, 4, 669

    CrossRef

  26. 26
    Christina K. Ullrich, Charles B. Berde, Amy Louise Billett, Oncology of Infancy and Childhood, 2009,

    CrossRef

  27. 27
    Ulrike M. Stamer, Lan Zhang, Frank Stüber, Impact of genetic variants on pain and analgesia, European Journal of Pain Supplements, 2008, 2, S1
  28. 28
    Paul C. Rousseau, Recent Literature, Journal of Palliative Medicine, 2008, 11, 5, 799

    CrossRef